Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$4.02 - $16.84 $23,717 - $99,356
-5,900 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$9.37 - $12.12 $55,282 - $71,508
5,900 New
5,900 $62,000
Q2 2020

Jul 27, 2020

SELL
$11.21 - $18.15 $83,290 - $134,854
-7,430 Closed
0 $0
Q3 2019

Oct 17, 2019

BUY
$15.33 - $23.85 $113,901 - $177,205
7,430 New
7,430 $134,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $95.4M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.